Catalyst
Slingshot members are tracking this event:
Advisory Committee meeting to discuss Probuphine, a subdermal implant for the maintenance treatment of opioid addiction
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Braeburn Pharmaceuticals |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 12, 2016
Occurred Source:
https://braeburnpharmaceuticals.com/titan-pharmaceuticals-and-braeburn-pharmaceuticals-announce-fda-advisory-committee-recommends-approval-of-probuphine-first-6-month-implant-to-treat-opioid-addiction/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Probuphine, Opioid Dependence, Adcom
